Abstract:Background: The equine infectious anemia virus (EIAV) is a lentivirus of the Retrovirus family, which causes persistent infection in horses often characterized by recurrent episodes of high fever. It has a similar morphology and life cycle to the human immunodeficiency virus (HIV). Its transmembrane glycoprotein, gp45 (analogous to gp41 in HIV), mediates membrane fusion during the infection. However, the post-fusion conformation of EIAV gp45 has not yet been determined. EIAV is the first member of the lentiviruses for which an effective vaccine has been successfully developed. The attenuated vaccine strain, FDDV, has been produced from a pathogenic strain by a series of passages in donkey dermal cells. We have previously reported that a V/I505T mutation in gp45, in combination with other mutations in gp90, may potentially contribute to the success of the vaccine strain. To this end, we now report on our structural and biochemical studies of the gp45 protein from both wide type and vaccine strain, providing a valuable structural model for the advancement of the EIAV vaccine.Results: We resolved crystal structures of the ecto-domain of gp45 from both the wild-type EIAV and the vaccine strain FDDV. We found that the V/I505T mutation in gp45 was located in a highly conserved d position within the heptad repeat, which protruded into a 3-fold symmetry axis within the six-helix bundle. Our crystal structure analyses revealed a shift of a hydrophobic to hydrophilic interaction due to this specific mutation, and further biochemical and virological studies confirmed that the mutation reduced the overall stability of the six-helix bundle in post-fusion conformation. Moreover, we found that altering the temperatures drastically affected the viral infectivity.Conclusions: Our high-resolution crystal structures of gp45 exhibited high conservation between the gp45/gp41 structures of lentiviruses. In addition, a hydrophobic to hydrophilic interaction change in the EIAV vaccine strain was found to modulate the stability and thermal-sensitivity of the overall gp45 structure. Our observations suggest that lowering the stability of the six-helix bundle (post-fusion), which may stabilizes the pre-fusion conformation, might be one of the reasons of acquired dominance for FDDV in viral attenuation.

Construction and Characterization of EIAV Vaccine Infectious Clones Labeled with FLAGTM or 6 His-tag

Construction of EIAV Infectious Clone with S2 Gene Dominant Negative Mutation

Construction of an Infectious Clone Within the V4 Region of Gp90 Surface Protein of EIAV by N-glycosylation Revers-Mutations

[Cloning, Expression and Preparation of Polyclonal Antibody for IBDV Non-Structure Protein Gene].

Construction and Expression of the Eukaryotic Expression Vector Pci-Chil-2-egfp and Enhancement of AIV Vaccine

Construction of an Infectious Clone Within the V3 Region of Gp90 Surface Protein of EIAV by N-glycosylation Revers-mutations

Construction and Characterization of 3A-Epitope-tagged Foot-And-Mouth Disease Virus

Amino Acid Mutations of the Infectious Clone from Chinese EIAV Attenuated Vaccine Resulted in Reversion of Virulence.

Development of a Molecular Clone of Chinese Equine Infectious Anemia Virus Donkey Adapted Strain

[Construction of an Infectious Clone of Equine Infectious Anemia Virus by N-glycosylation Reverse-Mutations].

Cloning and sequencing of the full genome of equine infectious anemia virus provirus DNA

Combined amino acid mutations occurring in the envelope closely correlate with pathogenicity of EIAV

Long Terminal Repeat Sequences from Virulent and Attenuated Equine Infectious Anemia Virus Demonstrate Distinct Promoter Activities.

A Pilot Study on Interaction Between Donkey Tetherin and EIAV Stains with Different Virulent and Replication Characteristics.

Complete Sequence of Proviral DNA of Equine Infectious Anemia Virus Strain L

Structural and Biochemical Insights into the V/I505T Mutation Found in the EIAV Gp45 Vaccine Strain

Cloning, Expression and Preliminary Crystallographic Analysis of the Equine Infectious Anaemia Virus (EIAV) Gp45 Ectodomain

An Attenuated EIAV Vaccine Strain Induces Significantly Different Immune Responses from Its Pathogenic Parental Strain Although with Similar in Vivo Replication Pattern

[Comparison of Proviral Genomes Between the Chinese EIAV Donkey Leukocyte-Attenuated Vaccine and Its Parental Virulent Strain].

Combined immunity of DNA vector and recombinant vaccinia virus expressing Gag proteins of equine infectious anemia virus

[Expression and Immunogenicity of Equine Infectious Anemia Virus Membrane Protein GP90].